Cargando…
Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis – The promise of DNA methylation and molecular biomarkers
Cholangiocarcinoma (CCA) is a highly fatal malignancy of the bile ducts that arises in up to 20% of patients with primary sclerosing cholangitis (PSC). Current detection methods for CCA display suboptimal sensitivity and/or specificity, and there is no evidence-based screening strategy for CCA in pa...
Autores principales: | Vedeld, Hege Marie, Folseraas, Trine, Lind, Guro Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479288/ https://www.ncbi.nlm.nih.gov/pubmed/32939446 http://dx.doi.org/10.1016/j.jhepr.2020.100143 |
Ejemplares similares
-
Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile
por: Vedeld, Hege Marie, et al.
Publicado: (2021) -
Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer
por: Vedeld, Hege Marie, et al.
Publicado: (2018) -
Survey uncovering variations in the management of primary sclerosing cholangitis across Europe
por: Eliasson, Johanna, et al.
Publicado: (2022) -
PoDCall: positive droplet calling and normalization of droplet digital PCR DNA methylation data
por: Jeanmougin, Marine, et al.
Publicado: (2022) -
Challenges of Cholangiocarcinoma Detection in Patients with Primary Sclerosing Cholangitis
por: Tabibian, James H., et al.
Publicado: (2012)